Dr. Ricardo Correa breaks down acromegaly—from subtle early signs and delayed diagnosis to treatment strategies and new meds.

Q3 2025 Management View R. Struthers, Founder, President, CEO & Director, highlighted, "It's a rare privilege to be part of a ...

Launched in the U.S. with Encouraging Early Feedback from Patients and Physicians, and Positive Reimbursement Trends ...

Crinetics Pharma (($CRNX)) has held its Q3 earnings call. Read on for the main highlights of the call. Crinetics Pharma’s recent earnings call ...

Please provide your email address to receive an email when new articles are posted on . Real-world data from the long-term ACROSTUDY show the growth hormone receptor antagonist pegvisomant is safe and ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. A higher percentage of adults with acromegaly were ...

The journal Pituitary has highlighted research led by Manel Puig, head of the Endocrine, Thyroid and Obesity Research Group ...

Kerry Breen is a news editor at CBSNews.com. A graduate of New York University's Arthur L. Carter School of Journalism, she previously worked at NBC News' TODAY Digital. She covers current events, ...

The diagnosis of Acromegaly is confirmed by Growth Hormone Suppression Test. Other tests like Insulin-like Growth Factor-1 levels, X-rays, MRI and CT scan can also be used to detect acromegaly. The ...

A personalized treatment protocol was more effective for management of acromegaly -- also known as gigantism -- than the usual trial-and-error approach, the ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...